This site uses cookies. By continuing to use this site you agree to our use of cookies. To find out more, see our Privacy and Cookies policy.
Skip to the content

IOP A community website from IOP Publishing

Browse events




Conference

The new Process Validation Life-Cycle Approach and the need to apply statistical tools to demonstrate Process Capability as per the new PV definition

About this event

Web site
bit.ly/rvlncm…
When
15 Dec 2011
Where
online training webinars, Wilmington | DE | Zip 19801, United States
Organiser
GlobalCompliancePanel
Contact address
webinars web
online training webinar
Suite 1200
Wilmington
Delaware
United States
Tel
8004479407
Fax
3022886884
E-mail
webinars@globalcompliance…

This webinar will describe the new Process Validation Life-Cycle Approach as defined in the revised FDA guideline. The three stages will be described in detail including: Process Design, Process Qualification and the Continued Process Verification.

For each stage, the discussion will focus on the procedures, documentation and statistical tools that should be used to effectively complete each task. In particular, the new definition requires the collection and evaluation of data to demonstrate that the process is capable to consistently meet the pre-defined specifications. For that purpose, the tools selected to evaluate the collected data are key elements in complying with the guideline. Even for existing processes, the approach requires to start at Stage 3 with the Continued Process Verification which will still require an effective use of tools to analyze the collected data to determine that your process is capable. The session will describe these tools and their application in addition to the conditions that must be present for them to be effective.

Why you should attend: The new FDA Guideline on Process Validation changes the entire approach to these requirements by applying a Life-Cycle concept including a Continuous Process verification step and making it clear that the process is validated continuously by collecting and evaluating data from our process to determine process capability. The other key element is the critical role of the development group to establish the process conditions and specifications with documented justification for the parameter ranges and process controls strategies. The question that most pharmaceutical management personnel have is: How do we apply these new approaches to existing processes? What kind of controls do we need? For the Continuous process verification, What tools do we need to implement to collect and analyze our data to determine if our process is capable and is considered validated? Many of the recommended tools have a statistical basis and there is a need to bring this knowledge base/expertise to our companies to be able to effectively use tools such as a Process Capability analysis and process control charts.

Areas Covered In the Session:
Process Validation Life Cycle Approach
Process Design
Process Qualification
Continued Process Verification
Process Capability
Application of new approach to existing processes
Who will benefit:
Quality
Manufacturing
Development
Validation Personnel
Management

Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00

webinars@globalcompliancepanel.com
http://www.globalcompliancepanel.com

Phone: 800-447-9407
Fax: 302-288-6884